HARMONY Workshop: Meaningful Outcomes for HMs

We are organizing a workshop on the definition of meaningful outcomes for hematological malignancies on 23 and 24 November 2017 at Takeda. Takeda is one of the 51 HARMONY Alliance Partners.

---

Together with 60 invited stakeholders we will discuss outcomes relevant to all stakeholders. The objectives of the workshop are to: 

• Brainstorm, exchange, and generate ideas regarding a list of outcomes relevant to all stakeholders. 
• Generate and group (by HM) a description of outcomes and in addition a list of standard core outcomes that are valid for all HMs: these will of value to all stakeholders participating in the workshop and will be validated at a later time.

---

Practical Information

• Date: 23 and 24 November 2017;

• Timeframe:  23 November: Begins at 11:00 hrs | 24 November: Ends at 13:30 hrs.;

• Venue: Takeda Pharmaceuticals International, 61 Aldwych , WC2B 4AE London, United Kingdom;

• Brief description: The agenda for this workshop focuses on outcomes definition, integration between HARMONY Work Packages 2 and 6 and determining priorities for the next few months. The workshop will be a follow up to the 2nd HARMONY General Assembly held in October 2017 in Berlin, Germany and will focus on five disease areas (MM, MDs &AML, CLL &NHL, ALL and childhood HMs);

• Link to the detailed programe;

• This Workshop is organized by the leadership of HARMONY Work Packages 2 and 6.

---

Event registration is by invitation only.

---

---

Are you interested in starting your research project while using Big Data analyses generated by HARMONY? Join our Alliance and become an Associate Member. Please contact the Coordination Office at harmonyoffice@ibsal.es.

---

Receive the latest news. Click here to subscribe!